Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation

Stacey Knight(Intermountain Medical Center), Joseph B. Muhlestein(University of Utah), Roger M. Mills(Janssen (Belgium)), Viet T. Le(Intermountain Medical Center), T. Jared Bunch, Benjamin D. Horne(Stanford University), Raymond O. McCubrey(Intermountain Medical Center), Žhong Yuan(Janssen (United States)), Scott C. Woller(University of Utah)

Therapeutic Advances in Cardiovascular Disease

February 25, 2016

10.1177/1753944716634563

Cited by 1

Related Papers

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation

|EP Europace|2024|537

Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study

|Heart Rhythm|2015|497

Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease

|New England Journal of Medicine|1976|480

Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection

|American Journal of Respiratory and Critical Care Medicine|2018|408

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure

|Journal of the American College of Cardiology|1999|323